1998
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial
Casson P, Santoro N, Elkind-Hirsch K, Carson S, Hornsby P, Abraham G, Buster J. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertility And Sterility 1998, 70: 107-110. PMID: 9660430, DOI: 10.1016/s0015-0282(98)00121-6.Peer-Reviewed Original ResearchConceptsHigh-density lipoproteinInsulin-like growth factorLevels of DHEADHEA therapySerum DHEAImmune indicesFree insulin-like growth factorDual-energy X-ray absorptiometry scanX-ray absorptiometry scansA1 levelsGrowth factorLiver function testsInsulin-sensitizing propertiesRatio of IGFSmall study sizeSix-month trialPostdose levelsPremenopausal rangePostmenopausal womenIGFBP-3Function testsInsulin sensitivityReferral practicesParallel trialMAIN OUTCOME
1997
Effect of postmenopausal estrogen replacement on circulating androgens.
Casson P, Elkind-Hirsch K, Buster J, Hornsby P, Carson S, Snabes M. Effect of postmenopausal estrogen replacement on circulating androgens. Obstetrics And Gynecology 1997, 90: 995-8. PMID: 9397118, DOI: 10.1016/s0029-7844(97)00538-3.Peer-Reviewed Original ResearchConceptsEstrogen replacement therapyMenopausal estrogen replacement therapySerum androgen levelsPostmenopausal womenReplacement therapySex hormonesAndrogen levelsPlacebo-controlled crossover studyAdrenal androgen deficiencyMean serum E2Postmenopausal estrogen replacementEstrogen replacementSerum dehydroepiandrosteroneAndrogen deficiencyBioavailable testosteroneSerum E2Crossover studyTreatment armsAndrogen replacementAdrenal effectsPrevious randomizedPg/Micrograms/TestosteroneSerum samples